Severe rhabdomyolysis due to rosuvastatin in a liver transplant subject with human immunodeficiency virus and immunosuppressive therapy-related dyslipidemia

Rosuvastatin-Associated Adverse Effects and Drug-Drug Interactions in the Clinical Setting of Dyslipidemia

(2010) Michael S. Kostapanos et al.   American Journal of Cardiovascular Drugs

Metabolic syndrome and liver transplantation: A review and guide to management

(2010) Kymberly D.S. Watt et al.   JOURNAL OF HEPATOLOGY

Severe rhabdomyolysis associated with raltegravir use

(2009) Teresa R Zembower et al.   AIDS

Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trial

(2009) Elisabeth Aslangul et al.   AIDS

Safety and Efficacy of Raltegravir in HIV-Infected Transplant Patients Cotreated with Immunosuppressive Drugs

(2009) L. Tricot et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Human Immunodeficiency Virus and Highly Active Antiretroviral Therapy–Associated Metabolic Disorders and Risk Factors for Cardiovascular Disease

(2009) Erdembileg Anuurad et al.   Metabolic Syndrome and Related Disorders

Severe Rhabdomyolysis and Acute Renal Failure Secondary to Concomitant Use of Simvastatin With Rapamycin Plus Tacrolimus in Liver Transplant Patient

(2009) C. Dopazo et al.   TRANSPLANTATION PROCEEDINGS

Population pharmacokinetics of rosuvastatin: implications of renal impairment, race, and dyslipidaemia

(2008) Tsang-Bin Tzeng et al.   CURRENT MEDICAL RESEARCH AND OPINION